Skip main menu Accessibility Free guides | Investor relations | Careers | About us | Contact us | Press
My accounts Log in/out

Hargreaves Lansdown
 

Legal & General Group plc Ordinary 2.5p Shares (LGEN)

Sell : 119.50p | Buy : 119.70p | down 1.20p
Prices delayed by at least 15 minutes

Company overview

The Group's core activities are the provision of long term insurance, investment management and general insurance services. It has operations in the United Kingdom, France, Germany, the Gulf, India, Egypt the Netherlands and the United States.  As at end-March 2011 it had total funds under management of £356 billion. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

HL Comment (1 November 2011)

The group's third quarter results (01Nov2011) proved to be broadly in line with analyst forecasts. Worldwide sales over the nine month period came in at £1.33 billion, virtually flat on the same period last year (£1.34 billion), whilst management’s concentration on cash generation continued to show progress - operational cash rose by 17% to £736 million (Q3 YTD 2010: £628 million). Sales grew across its Protection (+2%), Savings (+2%) and International (+10%) businesses, with management noting that the group was "reaping the benefits of rising individual and corporate prudence in the UK as the move from indebtedness to saving continues".

Negative Points:

  • Worldwide sales for the period proved to be flat.
  • While a net inflow of £4.8 billion in funds to the group was reported, this was down from the £10.6 billion enjoyed during the same nine month period of 2010.
  • Sales in India, the Netherlands and Egypt declined by 46%, 19% and 18% respectively.
  • Management previously identified a concern that an increasing trend for legislative intervention may potentially bring forced changes to the company.
  • The group lacks the scale of geographical diversification enjoyed by rivals such as Aviva and Prudential.
  • In line with the broader industry, there are risks arising from exposure to bond markets, movements in interest rates, along with foreign currency exchange rate fluctuation.

Positive Points:

  • Management's focus on cash generation in order to increase both investment and shareholder returns continues to progress. The board noted that it was "set to beat its annual cash generation targets, with operational cash up by 17% and net cash rising by 15%.
  • Assisted by increased cash generation, the half year dividend was increased by 25%.
  • The group continues to highlight a strong balance sheet. At the half year point, the group reported an Insurance Group Directive (IGD) surplus of £4.0 billion.
  • More than compensating for falls elsewhere in the world, sales for its US business increased by 50% to $81 million (Q3 2010 YTD: $54 million). This has followed product changes introduced in 2010 and a focus on key distribution channels.
  • L&G said it has recently received a permit to set up a representative office in China.

Consensus:

On balance, market consensus indicates a strong hold.

All yield figures are variable and not guaranteed.

What the Brokers Say

  • Heatbar summary of What the Brokers Say
    Strong
    Sell
    Strong
    Buy
  • Strong Buy: 8
    Buy: 3
    Neutral: 7
    Sell: 0
    Strong Sell: 2
    Total: 20

This is not a recommendation, it represents the consensus view of a basket of brokers. If less than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.

View Report & Accounts

All report and accounts are provided by SharesLibrary.

By downloading either the annual or interim report you are confirming you are happy to receive content from SharesLibrary, which is not provided or issued by Hargreaves Lansdown.

Important dates

Future events

Final Results 7-03-2012

Past events

Interim Management Statement 9-11-2011
Quarter 3 Results 1-11-2011
Interim Dividend Payment Date 3-10-2011
Interim Ex-Dividend Date 7-09-2011
Interim Management Statement 3-08-2011
Interim Results 3-08-2011
Final Dividend Payment Date 1-06-2011
AGM 25-05-2011
Interim Management Statement 4-05-2011
Final Ex-Dividend Date 20-04-2011
Annual Report 14-04-2011
Final Results 17-03-2011
Quarter 3 Results 9-11-2010
Interim Management Statement 9-11-2010
Trading Announcement 9-11-2010
Trading Announcement 22-10-2010
Interim Dividend Payment Date 1-10-2010
Interim Ex-Dividend Date 1-09-2010
Interim Results 4-08-2010
Final Dividend Payment Date 1-06-2010
AGM 26-05-2010
Interim Management Statement 5-05-2010
Annual Report 23-04-2010
Final Ex-Dividend Date 14-04-2010
Final Results 23-03-2010
Interim Management Statement 17-02-2010
Trading Announcement 4-11-2009
Quarterly Results 3-11-2009
Interim Dividend Payment Date 1-10-2009
Interim Ex-Dividend Date 2-09-2009
Interim Results 4-08-2009
Final Dividend Payment Date 1-06-2009
AGM 27-05-2009
Trading Announcement 13-05-2009
Trading Announcement 23-04-2009
Final Ex-Dividend Date 15-04-2009
Final Results 25-03-2009
Trading Announcement 29-01-2009
Quarterly Results 16-10-2008
Trading Announcement 16-10-2008
Interim Dividend Payment Date 1-10-2008
Interim Ex-Dividend Date 3-09-2008
Interim Results 1-08-2008
Final Dividend Payment Date 19-05-2008
AGM 14-05-2008
Final Ex-Dividend Date 16-04-2008
Final Results 18-03-2008
Quarterly Results 10-01-2008


Fundamental Data

Values are quoted in the stock's local currency: British pound.

Year Ending Revenue
(m)
Profit Before Tax
(m)
EPS
(p)
P/E Ratio PEG EPS Growth
(%)
Total Dividend Dividend Yield
31-12-2010 5,348.00 1,307.00 14.07 6.90 n/a (5.00) 4.75 4.90
31-12-2009 5,275.00 1,239.00 14.82 5.40 n/a n/a 3.84 4.80
31-12-2008 5,895.00 (2,153.00) (17.88) n/a n/a n/a 4.06 5.30
31-12-2007 4,793.00 795.00 11.24 11.60 n/a (53.00) 5.97 4.60
31-12-2006 4,286.00 1,929.00 24.12 6.50 0.10 68.00 5.55 3.50

Latest LGEN Director Deals

Traded Action Notifier Position Price Amount Value
1-02-2012 Buy John M Stewart Non-Executive Chairman 116.70p 5,785.00 £6,751.10
1-02-2012 Buy John Pollock Executive Director 117.25p 124.00 £145.39
1-02-2012 Buy Rudy Markham Non-Executive Director 116.70p 1,717.00 £2,003.74
1-02-2012 Buy Julia Wilson Independent Non-Executive Director 116.70p 1,326.00 £1,547.44
1-02-2012 Buy Nigel Wilson Group CFO 117.25p 124.00 £145.39
1-02-2012 Buy Stuart Popham Independent Non-Executive Director 116.70p 1,532.00 £1,787.84
1-02-2012 Buy Tim J Breedon CEO 117.25p 124.00 £145.39
1-02-2012 Buy Nick Prettejohn Independent Non-Executive Director 116.70p 2,150.00 £2,509.05
1-02-2012 Buy Mark Gregory Group Executive Director 117.25p 124.00 £145.39
1-02-2012 Buy Clara Furse Independent Non-Executive Director 116.70p 1,326.00 £1,547.44
30-01-2012 Buy Michael E Fairey Independent Non-Executive Director 116.70p 1,532.00 £1,787.84
3-01-2012 Buy John Pollock Executive Director 103.90p 139.00 £144.42
3-01-2012 Buy Stuart Popham Independent Non-Executive Director 104.10p 1,718.00 £1,788.44
3-01-2012 Buy Julia Wilson Independent Non-Executive Director 104.10p 2,579.00 £2,684.74
3-01-2012 Buy Michael E Fairey Independent Non-Executive Director 104.10p 1,718.00 £1,788.44
3-01-2012 Buy Nigel Wilson Group CFO 103.90p 139.00 £144.42
3-01-2012 Buy Nick Prettejohn Independent Non-Executive Director 104.10p 2,410.00 £2,508.81
3-01-2012 Buy Tim J Breedon CEO 103.90p 139.00 £144.42
3-01-2012 Buy Clara Furse Independent Non-Executive Director 104.10p 1,487.00 £1,547.97
3-01-2012 Buy Henry Staunton Non-Executive Director 104.10p 4,495.00 £4,679.30
3-01-2012 Buy Mark Gregory Group Executive Director 103.90p 139.00 £144.42
3-01-2012 Buy Rudy Markham Non-Executive Director 104.10p 1,925.00 £2,003.92
3-01-2012 Buy John M Stewart Non-Executive Chairman 104.10p 6,485.00 £6,750.88
1-12-2011 Buy Tim J Breedon CEO 106.30p 136.00 £144.57
1-12-2011 Buy Michael E Fairey Independent Non-Executive Director 105.60p 2,604.00 £2,749.82
1-12-2011 Buy Nick Prettejohn Independent Non-Executive Director 105.60p 6,020.00 £6,357.12
1-12-2011 Buy Mark Gregory Group Executive Director 106.30p 136.00 £144.57
1-12-2011 Buy Clara Furse Independent Non-Executive Director 105.60p 1,465.00 £1,547.04
1-12-2011 Buy Henry Staunton Non-Executive Director 105.60p 9,708.00 £10,251.65
1-12-2011 Buy John Pollock Executive Director 106.30p 136.00 £144.57
1-12-2011 Buy Rudy Markham Non-Executive Director 105.60p 5,050.00 £5,332.80
1-12-2011 Buy John M Stewart Non-Executive Chairman 105.60p 7,523.00 £7,944.29
1-12-2011 Buy Nigel Wilson Group CFO 106.30p 136.00 £144.57
1-12-2011 Buy Stuart Popham Independent Non-Executive Director 105.60p 2,604.00 £2,749.82

Any Overview and Comment is provided by Hargreaves Lansdown. What the Brokers Say, Important Dates and Financials are supplied by Digital Look Ltd. Prices delayed by at least 15 minutes.



Hargreaves Lansdown is authorised and regulated by the Financial Services Authority.

Disclaimer | Important Investment Notes | Terms & Conditions | Privacy Policy | Site map | Email this to a friend | Accessibility